Concomitant inhibition of both pathways resulted in depletion of this chemoresistant subpopulation, thereby abrogating tumor regrowth after docetaxel treatment in vivo. This effect is presumably due to the modulation of PI3K/AKT and Bcl2 by respectively the Notch and Hh pathway [138]. The gene discussed is BCL2; the disease is neoplasm.